He almost needs no introduction, and yet, we would be remiss in not sharing a few of his finest traits: A contagious passion for our industry, an affinity for finding better solutions and an enthusiasm to share his insight and knowledge.
Jeff Elkins, a seasoned medtech executive with experience in both startups and larger companies, was recently hired as chief operating officer of InterVene, a Fogarty Institute graduate that has developed a minimally invasive device for the treatment of venous disease in the legs.
What started as a vision to use a mobile makerspace as a tool to inspire young, chronically ill patients to learn, create and innovate – and help make lengthy hospital stays more palatable – is now becoming a reality, thanks to the generous support of Sheri Sobrato Brisson, a long-time supporter of seriously and chronically ill children,
With luminaries such as Joe Biden, Bill Gates and Anne Wojcicki as keynote speakers, the J.P. Morgan Healthcare conference continues to be one of the most prominent events of its kind. This January, it was once again hosted in San Francisco, widely considered one of the meccas of the medtech industry.
Unplanned pregnancies could someday be a thing of the past, thanks to Cadence, a company started by Amanda French, one of the new Ferolyn Fellows.
As a child, she knew she wanted to be in healthcare, potentially as a doctor – she loved to help people and had a knack for science and math,
Every now and then you meet someone who deeply inspires you to strive to be the best individual and leader you can be – and who shows you the value and role of soft skills, like grit, creativity and communication, to not only survive the daily challenges we all face, but to thrive despite them.
Lower-cost, more-effective treatments are the hallmark of many Fogarty Institute companies, and that is the principle Healyx is living up to with its device that provides gold standard care for a chronic problem at a significant cost reduction.
Non-healing wounds are a critical global issue, with over eight million Medicare patients afflicted at an annual cost of $31.7 billion in the U.S.
This year’s annual Thomas J. Fogarty Lecture marked a milestone with the celebration of its 20thanniversary. The series, hosted by Stanford Biodesign and co-sponsored by the Fogarty Institute, started as a gathering to discuss and promote medical innovation with approximately 30 people in attendance. Since then, it has grown into a preeminent opportunity to learn from the most notable innovators in health technology.
A banking partner who truly understands your industry and unique business challenges can make all the difference to a company’s success. And that’s what Silicon Valley Bank aims to do – in their words, “help innovators, enterprises and investors move bold ideas forward, fast.”
A key player in that ambitious agenda is Kevin Longo,